Benchmarking Glaucoma
What does analysis of the last five years of literature on glaucoma tell us about the priorities of the field and the major contributors to it?
Mark Hillen |
Glaucoma is second leading cause of blindness globally, after cataracts, but provides an even greater challenge: glaucoma-related blindness is permanent. This is a major driving factor for clinical research into glaucoma therapies.
To provide insight into the past and predictions for the future of the field, a series of metrics were applied to the last five years of the published literature. We asked:
- What are the major topics for the field?
- Which publications have the greatest impact?
- How is the knowledge available online?
- Who are the most prolific authors?
PubMed, was searched for glaucoma* with results limited to the last five years, in humans (for a clinical focus). The data were analyzed in Microsoft Excel 2013.
